Company Profile
Takeda Stock Price, News & Analysis
- Ticker:
- TAK
- Exchange:
- NYSE
- Sector:
- Biopharma
- Location:
- Japan and listed in the U
Stock performance
17.02 USD (+1.79%)
Close
Last updated: August 6, 2026
48B USD
Market cap
Why the stock is moving
As of Aug 6, 2026, TAK closed up 1.79% at $17.02. No new same-company headline was identified in the current news window.
Company overview
Business overview
Takeda is a global pharmaceutical company with broad exposure to gastroenterology, oncology, rare disease, plasma-derived therapies, and vaccines. Its business is defined by scale, diversification, and a strong international footprint.
Geographic Base and Sector Classification
Takeda is headquartered in Japan and listed in the U.S. market. It sits in global large-cap pharma rather than biotech.
Business Model Characteristics
The company generates value through branded medicines, portfolio diversification, and disciplined R&D reinvestment. Investors watch pipeline progress, earnings stability, and geographic breadth.
Position Within the Biotechnology Landscape
Takeda sits in the top tier of global pharma. It is less binary than biotech, but its pipeline and launch cadence still matter to the market.
Future catalysts
Takeda’s catalysts are oncology, rare disease, and GI portfolio execution, plus any pipeline update that helps the growth mix evolve. The company will be watched for broad commercial stability.
Recent news
- 01
- 02
Similar stocks
Peer names with similar commercial maturity, therapeutic overlap, or catalyst patterns.
Frequently Asked Questions
What is the current stock price of Takeda (TAK)?
Takeda (TAK) most recently closed at 17.02 USD, a +1.79% move versus the previous session.
What is the market cap of Takeda (TAK)?
Takeda currently has a market capitalization of 48B USD on BioPharmSignal.
What does Takeda do?
Takeda is a global pharmaceutical company with broad exposure to gastroenterology, oncology, rare disease, plasma-derived therapies, and vaccines. Its business is defined by scale, diversification, and a strong international footprint.
On which exchange is TAK stock listed?
Takeda (TAK) is associated with NYSE, Japan and listed in the U, Biopharma.
What is Takeda?
Takeda’s catalysts are oncology, rare disease, and GI portfolio execution, plus any pipeline update that helps the growth mix evolve.
Which conditions is Takeda targeting with Takeda?
Takeda is associated with oncology, rare disease based on its company overview and current catalyst commentary.
How does Takeda describe recent progress with Takeda?
Takeda’s catalysts are oncology, rare disease, and GI portfolio execution, plus any pipeline update that helps the growth mix evolve.
What future catalysts are investors watching for Takeda?
Takeda’s catalysts are oncology, rare disease, and GI portfolio execution, plus any pipeline update that helps the growth mix evolve. The company will be watched for broad commercial stability.